Temporomandibular disorder among metamphetamine user

  • Septyana Happysari Prosthodontic Residency Program Faculty of Dentistry, Universitas Indonesia Jakarta, Indonesia
  • Ira Tanti Prosthodontic Department Faculty of Dentistry, Universitas Indonesia Jakarta, Indonesia
Keywords: temporomandibular disorder, metamphetamine, muscle

Abstract

Cystalline metamphetamine or often called "shabu shabu" is a type of amphetamine which is the most often abused in Indonesia. Cinical symptoms of temporomandibular disorder (TMD) were found in 84.2% of 152 among amphe-tamine users. This case analysis aims to evaluate the treatment of TMD of muscular origin, with myofacial pain diagnosis. The chosen treatments are maximizing etiology-related education and supportive care that aims to reduce muscle mastication activities such as physical self-regulation, assisted muscle stretching, warm compresses, and administration of analgesics to reduce pain that patients often experience.

References

Roda RP, Bagan JV, Fernández JMD, Bazán SH, Soriano YJ. Review of temporomandibular joint pathology. Part I: classification, epidemiology and risk factors. Med Oral Patol Oral Cir Bucal 2007;12(4):292-8.

Winocur E, Gavish A, Voikovitch M, Emodi-Perlman A, Eli I. Drugs and bruxism: A critical review. J Orofac Pain 2003;17(2):99-111.

Herindrasti VLS. Indonesia intiative in combating and preventing drugs abuse: from “criminalization” to “decri-minalization” policy. 2020.

Goverment NSW. https://druginfo.sl.nsw.gov.au/drugs/a-to-z-of-drugs/ice-speed-other-methamphetamines. State Library. https://druginfo.sl.nsw.gov.au/drugs/a-to-z-of-drugs/ice-speed-other-methamphetamines. Pub-lished 2019.

Paramitha I, Tanti I, Himawan LS. Risk factors for temporomandibular disorders among amphetamine users in indonesia. Pesqui Bras Odontopediatria Clin Integr 2019;19(1):1-7. doi:10.4034/PBOCI.2019.191.142

Mukherjee A, Dye BA, Clague J, Belin TR, Shetty V. Methamphetamine use and oral health-related quality of life. Qual Life Res 2018;27(12):3179-90. doi:10.1007/s11136-018-1957-6

Enguelberg-Gabbay JV, Schapir L, Israeli Y, Hermesh H, Weizman A, Winocur E. Methadone treatment, bruxism, and temporomandibular disorders among male prisoners. Eur J Oral Sci 2016;124(3):266-71. doi: 10.1111/eos.12268

Shetty V, Harrell L, Murphy DA. Dental disease patterns in methamphetamine users findings in a large urban sample. J Am Dent Assoc 2015;146(12):875-85. doi:10.1016/j.adaj.2015.09.012

Robbins JL, Lorvick J, Lutnick A, Wenger L, Kral AH. Self-reported oral health needs and dental-care seeking behavior among women who use methamphetamine. Subst Use Misuse 2012;47(11):1208-13. doi:10.3109/ 10826084.2012.696228

De-Carolis C, Boyd GA, Mancinelli L, Pagano S, Eramo S. Methamphetamine abuse and “meth mouth” in Europe. Med Oral Patol Oral Cir Bucal 2015;20(2):e205-e10. doi:10.4317/medoral.20204

Okeson J. Management of temporomandibular disorder and occlusion. 8th ed. Lexington, Kentuky: Elsevier; 2020.

Tullberg M, Ernberg M. Long-term effect on tinnitus by treatment of temporomandibular disorders: A two-year follow-up by questionnaire. Acta Odontol Scand 2006;64(2):89-96. doi:10.1080/00016350500377842

Published
2020-12-17